Publications by authors named "Daniela Graham"

Claim this Profile
C
Correction: A retrospective natural history study in adult and juvenile patients with incident dermatomyositis and polymyositis using real world data.
David M Barnes, Daniela Graham, Cecilia E Borlenghi, Thomas Edwards, Stephen E Schachterle

Clin Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective natural history study in adult and juvenile patients with incident dermatomyositis and polymyositis using real world data.
David M Barnes, Daniela Graham, Cecilia E Borlenghi, Thomas Edwards, Stephen E Schachterle

Clin Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.
Jonathan I Silverberg, Robert S Kirsner, David J Margolis, Michael Tharp, Daniela E Myers, Daniela Graham

J Am Acad Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial.
Filip Van den Bosch, James Cheng-Chung Wei, Peter Nash, Francisco J Blanco, Daniela Graham

J Rheumatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
Joseph Fowler, Jeffrey Sugarman, Lawrence Sher, Chuanbo Zang, John L Werth, Daniela Graham

Dermatol Ther (Heidelb)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.
Manoli Vourvahis, Wonkyung Byon, Cheng Chang, Vu Le, Annette Diehl, Daniela Graham

Clin Pharmacol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis.
Kayo Fujita, Michio Yagi, Shinichi Moriwaki, Mizuki Yoshida, Daniela Graham

J Dermatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis.
Jon T Giles, Alexis Ogdie, Juan J Gomez Reino, Philip Helliwell, Rebecca Germino, Daniela Graham

RMD Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Philip Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Daniela Graham

Ann Rheum Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Philip J Mease, Dafna D Gladman, Daniela Graham

RMD Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab.
Désirée van der Heijde, Dafna D Gladman, Oliver FitzGerald, Arthur Kavanaugh, Daniela Graham

J Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
Uma Mahadevan, Marla C Dubinsky, Chinyu Su, Nervin Lawendy, Thomas V Jones, Daniela Graham

Inflamm Bowel Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
Philip Mease, Stephen Hall, Oliver FitzGerald, Désirée van der Heijde, Joseph F Merola, Daniela Graham

N Engl J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis